ANDREA BOVA: Open Payments
NPI 1740652296 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,165 in 90 payments from 20 companies in 2025. Trend: 2023 $814 · 2024 $1,610 · 2025 $2,165
Food & beverage: $2,050Education: $115
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $370 |
| Janssen Biotech, Inc. | 14 | $273 |
| Lilly USA, LLC | 9 | $230 |
| ABBVIE INC. | 13 | $195 |
| Arcutis Biotherapeutics, Inc. | 3 | $160 |
| Organon LLC | 8 | $146 |
| Amgen Inc. | 4 | $96 |
| Botanix SB Inc | 5 | $92 |
| Galderma Laboratories, L.P. | 5 | $91 |
| PFIZER INC. | 4 | $85 |
Products named: Bimzelx, TREMFYA, TALTZ, SKYRIZI, Zoryve, VTAMA, OTEZLA, SOFDRA.
Industry payments across MO — which companies pay providers there.
